,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.0,Proctalgia,16651542,
1,22.0,Flushing,16651542,
2,22.0,Feeling abnormal,16651542,
3,22.0,Frequent bowel movements,16651542,
4,22.0,Restlessness,16651542,
5,22.0,Pain,16651542,
0,22.0,Photosensitivity reaction,16651556,
1,22.0,Sunburn,16651556,
2,22.0,Rash,16651556,
0,22.1,Haemorrhage,16651575,5
1,22.1,Cerebral infarction,16651575,6
0,22.0,Disseminated intravascular coagulation,16651604,6
0,22.0,Thrombotic microangiopathy,16651629,1
0,22.0,Cerebrovascular accident,16651643,4
0,22.1,Pericardial effusion,16651646,3
0,22.0,Pericardial effusion,16651650,6
1,22.0,Pleural effusion,16651650,2
0,22.1,Neuropathy peripheral,16651667,6
1,22.1,Disease progression,16651667,6
2,22.1,Unevaluable event,16651667,6
3,22.1,Vision blurred,16651667,3
4,22.1,Fatigue,16651667,3
5,22.1,Skin discolouration,16651667,3
6,22.1,Dry skin,16651667,3
7,22.1,Skin exfoliation,16651667,3
8,22.1,Bone decalcification,16651667,3
9,22.1,Underdose,16651667,6
10,22.1,Contusion,16651667,3
0,22.0,Pruritus,16651702,
0,22.1,Delirium,16651711,1
1,22.1,Thrombocytopenia,16651711,3
2,22.1,Leukocytosis,16651711,3
3,22.1,Dehydration,16651711,1
4,22.1,Pneumonia,16651711,5
5,22.1,Neutrophilia,16651711,3
6,22.1,Neutropenia,16651711,1
7,22.1,Vomiting,16651711,1
8,22.1,Leukopenia,16651711,1
9,22.1,Liver disorder,16651711,3
0,22.0,Alopecia,16651715,6
1,22.0,Hair texture abnormal,16651715,6
2,22.0,Hair disorder,16651715,6
3,22.0,Hair colour changes,16651715,6
0,22.0,Alopecia,16651716,6
1,22.0,Hair disorder,16651716,3
2,22.0,Hair texture abnormal,16651716,3
3,22.0,Hair colour changes,16651716,3
0,22.0,Death,16651743,
0,22.0,Hepatic enzyme increased,16651749,
0,22.0,Hair colour changes,16651752,3
1,22.0,Alopecia,16651752,3
2,22.0,Hair texture abnormal,16651752,3
3,22.0,Hair disorder,16651752,3
0,22.0,Hair colour changes,16651754,3
1,22.0,Hair disorder,16651754,3
2,22.0,Madarosis,16651754,3
3,22.0,Alopecia,16651754,3
4,22.0,Hair texture abnormal,16651754,3
0,22.0,Hair texture abnormal,16651760,3
1,22.0,Hair colour changes,16651760,3
2,22.0,Hair disorder,16651760,3
3,22.0,Alopecia,16651760,3
4,22.0,Madarosis,16651760,3
0,22.0,Disease progression,16651763,
0,22.0,Hair colour changes,16651768,3
1,22.0,Hair texture abnormal,16651768,3
2,22.0,Hair disorder,16651768,3
3,22.0,Alopecia,16651768,3
0,22.0,Disease progression,16651770,
0,22.0,Fall,16651779,
1,22.0,Spinal fracture,16651779,
0,22.0,Disease progression,16651784,
0,22.1,Disease progression,16651795,6
1,22.1,Platelet count decreased,16651795,6
2,22.1,Diarrhoea,16651795,3
3,22.1,Neuropathy peripheral,16651795,6
4,22.1,Underdose,16651795,6
5,22.1,Drug ineffective,16651795,6
6,22.1,Hair growth abnormal,16651795,6
7,22.1,Insomnia,16651795,6
0,22.0,White blood cell count decreased,16651811,6
0,22.0,Vomiting,16651826,
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16651826,
2,22.0,Nausea,16651826,
0,22.0,Drug hypersensitivity,16651845,
1,22.0,Pruritus,16651845,
2,22.0,Throat irritation,16651845,
0,22.0,Adrenal insufficiency,16651847,4
1,22.0,Latent autoimmune diabetes in adults,16651847,3
0,22.0,Cholangitis,16651872,3
1,22.0,Muscular weakness,16651872,1
0,22.0,Death,16651880,
0,22.0,Neoplasm progression,16651924,6
0,22.0,Hypotension,16651943,3
0,22.0,Nausea,16651947,6
0,22.0,Poisoning,16651959,1
0,22.1,White blood cell count decreased,16652000,6
1,22.1,Decreased appetite,16652000,6
2,22.1,Fatigue,16652000,6
3,22.1,Back pain,16652000,6
4,22.1,Anxiety,16652000,6
5,22.1,Constipation,16652000,6
6,22.1,Skin abrasion,16652000,6
7,22.1,Pain,16652000,6
8,22.1,Neutropenia,16652000,1
9,22.1,Incontinence,16652000,6
10,22.1,Erythema,16652000,6
11,22.1,Decubitus ulcer,16652000,6
12,22.1,Bone pain,16652000,6
13,22.1,Thrombocytopenia,16652000,1
14,22.1,Diarrhoea,16652000,1
15,22.1,Pain in extremity,16652000,6
16,22.1,Arthritis,16652000,6
0,22.0,Stomatitis,16652003,
1,22.0,Cerebral disorder,16652003,
2,22.0,Visual impairment,16652003,
0,22.0,Lung infection,16652038,6
0,22.0,Hair growth abnormal,16652047,6
1,22.0,Night sweats,16652047,3
2,22.0,Blood count abnormal,16652047,6
3,22.0,Nausea,16652047,3
4,22.0,Fatigue,16652047,3
5,22.0,Diarrhoea,16652047,6
6,22.0,Condition aggravated,16652047,3
7,22.0,Nail growth abnormal,16652047,6
0,22.1,Pain in extremity,16652048,2
1,22.1,Pharyngeal mass,16652048,6
2,22.1,Peripheral swelling,16652048,1
3,22.1,Oedema,16652048,6
4,22.1,Paraesthesia,16652048,1
5,22.1,Weight decreased,16652048,6
6,22.1,Balance disorder,16652048,6
7,22.1,Sensory loss,16652048,6
8,22.1,Gait inability,16652048,2
9,22.1,Hypoaesthesia,16652048,1
10,22.1,Blister,16652048,1
11,22.1,Diarrhoea,16652048,2
12,22.1,Haemorrhoids,16652048,6
13,22.1,Palmar-plantar erythrodysaesthesia syndrome,16652048,2
14,22.1,Prostatitis,16652048,6
15,22.1,Rash,16652048,6
16,22.1,Confusional state,16652048,6
0,22.0,Neoplasm progression,16652059,6
0,22.0,Neoplasm progression,16652062,3
0,22.0,Neoplasm progression,16652063,5
0,22.0,Urinary tract obstruction,16652078,6
1,22.0,Incorrect dose administered,16652078,6
2,22.0,Off label use,16652078,6
3,22.0,Haemorrhage urinary tract,16652078,6
0,22.1,Anaemia,16652107,
1,22.1,Urinary tract infection,16652107,
2,22.1,Confusional state,16652107,
3,22.1,Thrombocytopenia,16652107,
4,22.1,Sepsis,16652107,5
0,22.0,Product dose omission,16652193,6
1,22.0,Neoplasm progression,16652193,6
0,22.0,Product dose omission,16652250,6
1,22.0,Product use issue,16652250,6
2,22.0,Abdominal discomfort,16652250,6
0,22.0,Brain neoplasm,16652265,6
1,22.0,Second primary malignancy,16652265,6
0,22.0,Nasopharyngitis,16652278,1
0,22.1,Asthenia,16652311,6
1,22.1,Weight increased,16652311,6
2,22.1,Nausea,16652311,6
3,22.1,Balance disorder,16652311,6
4,22.1,Laziness,16652311,6
5,22.1,Fatigue,16652311,6
0,22.0,Disease progression,16652435,
0,22.0,Stomatitis,16652440,6
1,22.0,Leukopenia,16652440,6
2,22.0,Neutropenia,16652440,6
0,22.0,Lupus-like syndrome,16652460,3
1,22.0,Abdominal pain upper,16652460,3
0,22.0,Radiation pneumonitis,16652491,1
0,22.0,Ageusia,16652553,
1,22.0,Blood pressure increased,16652553,
0,22.0,Anaemia,16652555,
1,22.0,Decreased appetite,16652555,
2,22.0,Neuropathy peripheral,16652555,
3,22.0,Fatigue,16652555,
4,22.0,Hepatotoxicity,16652555,
5,22.0,Platelet count decreased,16652555,
6,22.0,Constipation,16652555,
0,22.0,Surgery,16652560,6
0,22.0,Pain,16652578,3
1,22.0,Bone pain,16652578,6
2,22.0,Back pain,16652578,3
3,22.0,Dysuria,16652578,3
4,22.0,Nausea,16652578,6
5,22.0,Ageusia,16652578,6
6,22.0,Gallbladder disorder,16652578,6
7,22.0,Fatigue,16652578,3
8,22.0,Diarrhoea,16652578,3
9,22.0,Skin haemorrhage,16652578,6
10,22.0,Hypertension,16652578,2
11,22.0,Skin exfoliation,16652578,3
12,22.0,Myalgia,16652578,6
13,22.0,Oral disorder,16652578,3
14,22.0,Feeling hot,16652578,3
0,22.0,Liver function test increased,16652600,
0,22.0,Malignant neoplasm progression,16652604,6
0,22.0,Hospice care,16652646,
0,22.0,Syncope,16652647,3
1,22.0,Diarrhoea,16652647,3
0,22.0,Therapy cessation,16652655,
1,22.0,Thrombosis,16652655,
0,22.0,Death,16652691,5
0,22.0,Drug intolerance,16652725,
1,22.0,Diarrhoea,16652725,
0,22.0,Disease progression,16652730,
0,22.0,Chest pain,16652839,6
1,22.0,Dysphonia,16652839,6
2,22.0,Weight decreased,16652839,6
3,22.0,Stomatitis,16652839,6
4,22.0,Faecaloma,16652839,6
5,22.0,Taste disorder,16652839,6
6,22.0,Diarrhoea,16652839,6
7,22.0,Vomiting,16652839,6
8,22.0,Blood pressure increased,16652839,6
0,22.0,Alanine aminotransferase increased,16652897,2
1,22.0,Liver injury,16652897,2
0,22.0,Breast cancer,16652900,3
1,22.0,Type 2 diabetes mellitus,16652900,6
2,22.0,Drug interaction,16652900,6
0,22.0,Thrombocytopenia,16652983,6
0,22.0,Laryngeal oedema,16652990,1
1,22.0,Respiratory fatigue,16652990,1
0,22.0,Drug ineffective,16653025,6
1,22.0,Anaemia,16653025,6
2,22.0,Hypoalbuminaemia,16653025,6
0,22.0,Malignant neoplasm progression,16653071,6
1,22.0,Oedema peripheral,16653071,6
2,22.0,Renal disorder,16653071,6
3,22.0,Rash,16653071,6
0,22.0,Malignant neoplasm progression,16653073,6
1,22.0,Renal disorder,16653073,6
0,22.0,Tubulointerstitial nephritis,16653089,1
0,22.0,Pulmonary embolism,16653101,5
1,22.0,Pneumonia,16653101,5
2,22.0,Radiation pneumonitis,16653101,5
3,22.0,Toxic epidermal necrolysis,16653101,5
0,22.0,Diabetes mellitus,16653106,3
1,22.0,Hypertriglyceridaemia,16653106,3
2,22.0,Myocardial infarction,16653106,1
0,22.0,Vomiting,16653112,3
0,22.0,Hypersensitivity,16653156,6
1,22.0,Rash,16653156,6
2,22.0,Death,16653156,5
3,22.0,Renal failure,16653156,6
0,22.0,Nephrotic syndrome,16653158,6
1,22.0,Haematotoxicity,16653158,1
2,22.0,Neurotoxicity,16653158,1
0,22.0,Myalgia,16653193,6
1,22.0,Malignant neoplasm progression,16653193,6
0,22.0,Colorectal cancer,16653216,
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16653216,2
0,22.1,Drug ineffective,16653227,6
1,22.1,Prostatic specific antigen increased,16653227,6
0,22.0,Diabetes mellitus,16653249,6
0,22.0,Death,16653258,5
0,22.0,Confusional state,16653262,3
1,22.0,Asthenia,16653262,3
0,22.0,Immune-mediated necrotising myopathy,16653283,2
1,22.0,Myasthenia gravis,16653283,2
0,22.1,Dehydration,16653296,2
1,22.1,Constipation,16653296,2
2,22.1,Oral pain,16653296,6
3,22.1,White blood cell count decreased,16653296,2
4,22.1,Dizziness,16653296,6
5,22.1,Fall,16653296,6
6,22.1,Heart rate abnormal,16653296,6
7,22.1,Weight decreased,16653296,2
8,22.1,Oropharyngeal pain,16653296,6
9,22.1,Fatigue,16653296,2
10,22.1,Oral candidiasis,16653296,6
11,22.1,Weight fluctuation,16653296,6
12,22.1,Blood pressure decreased,16653296,6
13,22.1,Taste disorder,16653296,6
14,22.1,Blood pressure fluctuation,16653296,6
15,22.1,Respiration abnormal,16653296,6
16,22.1,Arrhythmia,16653296,6
17,22.1,Contusion,16653296,6
18,22.1,Decreased appetite,16653296,6
19,22.1,Nausea,16653296,2
20,22.1,Vomiting,16653296,2
21,22.1,Loss of consciousness,16653296,1
22,22.1,International normalised ratio increased,16653296,6
23,22.1,Oedema peripheral,16653296,6
24,22.1,Dyspepsia,16653296,2
25,22.1,Oral discomfort,16653296,6
0,22.0,Hormone-refractory prostate cancer,16653307,3
0,22.0,Subclavian vein thrombosis,16653332,3
1,22.0,Blepharitis,16653332,3
2,22.0,Axillary vein thrombosis,16653332,3
0,22.0,Malaise,16653339,1
0,22.0,Neutropenia,16653369,1
1,22.0,Anaemia,16653369,1
2,22.0,Gamma-glutamyltransferase increased,16653369,1
3,22.0,Drug interaction,16653369,1
0,22.0,Blood pressure increased,16653377,6
1,22.0,Skin disorder,16653377,6
2,22.0,Mucosal disorder,16653377,6
3,22.0,Dyspepsia,16653377,6
4,22.0,Blood pressure fluctuation,16653377,6
5,22.0,Eating disorder,16653377,6
0,22.1,Clostridium difficile colitis,16653378,6
1,22.1,Nephropathy toxic,16653378,3
2,22.1,Malignant neoplasm progression,16653378,5
3,22.1,Ankylosing spondylitis,16653378,6
4,22.1,Compression fracture,16653378,6
0,22.0,Hepatocellular injury,16653381,6
0,22.0,Urticaria,16653398,6
1,22.0,Eyelid oedema,16653398,6
0,22.0,Nail disorder,16653401,3
1,22.0,Lacrimation increased,16653401,3
2,22.0,Diarrhoea,16653401,3
0,22.0,Fall,16653403,1
1,22.0,Hypotension,16653403,1
0,22.0,Atrial fibrillation,16653437,3
0,22.0,Neoplasm progression,16653451,5
1,22.0,Saliva discolouration,16653451,2
2,22.0,Retching,16653451,3
3,22.0,Diarrhoea,16653451,3
4,22.0,Abdominal pain,16653451,3
0,22.0,Death,16653466,5
0,22.0,Death,16653469,5
0,22.0,Rash,16653509,6
0,22.0,Malignant neoplasm progression,16653623,5
0,22.1,Pulmonary alveolar haemorrhage,16653627,1
1,22.1,Pneumonitis,16653627,2
0,22.0,Febrile neutropenia,16653638,5
1,22.0,Sepsis,16653638,5
0,22.1,Anaemia,16653701,6
1,22.1,Dry skin,16653701,3
2,22.1,Rash,16653701,3
3,22.1,Neoplasm progression,16653701,3
4,22.1,Skin injury,16653701,3
0,22.0,Sleep talking,16653703,1
1,22.0,Death,16653703,5
0,22.0,Death,16653746,5
0,22.0,Deafness,16653753,3
1,22.0,Tympanic membrane perforation,16653753,6
2,22.0,Hypertension,16653753,2
3,22.0,Diarrhoea,16653753,1
0,22.1,Biliary sepsis,16653763,5
0,22.0,Metastases to bone,16653774,6
1,22.0,Breast cancer recurrent,16653774,6
0,22.1,Off label use,16653817,6
1,22.1,Pancytopenia,16653817,6
2,22.1,Product use issue,16653817,6
0,22.0,Sepsis,16653836,5
1,22.0,Blood alkaline phosphatase increased,16653836,6
2,22.0,Cardiac failure,16653836,5
3,22.0,Platelet count decreased,16653836,6
4,22.0,Respiratory distress,16653836,6
5,22.0,Aspartate aminotransferase increased,16653836,6
6,22.0,Blood lactate dehydrogenase increased,16653836,6
7,22.0,Multiple organ dysfunction syndrome,16653836,6
8,22.0,Blood creatine phosphokinase increased,16653836,6
9,22.0,Alanine aminotransferase increased,16653836,6
10,22.0,Blood urea increased,16653836,6
11,22.0,C-reactive protein increased,16653836,6
12,22.0,Haemoglobin decreased,16653836,6
13,22.0,Arthritis bacterial,16653836,6
14,22.0,White blood cell count decreased,16653836,6
0,22.0,Full blood count abnormal,16653839,6
0,22.1,Cellulitis,16653844,1
0,22.1,Sleep disorder,16653857,6
1,22.1,Red blood cell count decreased,16653857,6
2,22.1,Haemoglobin decreased,16653857,6
3,22.1,Pyrexia,16653857,6
4,22.1,Asthenia,16653857,3
5,22.1,Rash,16653857,3
6,22.1,Cystitis,16653857,6
7,22.1,Acne,16653857,6
8,22.1,Dyspnoea,16653857,6
9,22.1,Peripheral swelling,16653857,6
0,22.0,Diarrhoea,16653863,6
0,22.0,Erythema,16653895,1
1,22.0,Paraesthesia,16653895,1
2,22.0,Nausea,16653895,1
0,22.0,Renal impairment,16653936,2
0,22.1,Headache,16653955,3
1,22.1,Pollakiuria,16653955,3
2,22.1,Bradycardia,16653955,2
3,22.1,Headache,16653955,3
4,22.1,Swelling,16653955,3
5,22.1,Erythema,16653955,3
6,22.1,Product dose omission,16653955,6
7,22.1,Angina pectoris,16653955,6
8,22.1,Insomnia,16653955,3
9,22.1,Urinary incontinence,16653955,6
10,22.1,Heart rate decreased,16653955,1
11,22.1,Dizziness,16653955,6
12,22.1,Anxiety,16653955,2
13,22.1,Blood triglycerides increased,16653955,3
14,22.1,Osteoarthritis,16653955,6
15,22.1,Micturition urgency,16653955,3
16,22.1,Hyperhidrosis,16653955,2
17,22.1,Chest discomfort,16653955,3
18,22.1,Haemoglobin increased,16653955,3
19,22.1,Discomfort,16653955,6
20,22.1,Treatment noncompliance,16653955,6
0,22.0,Diverticulitis,16654039,6
1,22.0,Renal impairment,16654039,6
0,22.1,Lipase increased,16654053,1
0,22.0,Febrile neutropenia,16654059,1
1,22.0,Fatigue,16654059,1
2,22.0,Infection,16654059,1
3,22.0,Feeding disorder,16654059,1
4,22.0,Mucosal pain,16654059,1
5,22.0,Dyschezia,16654059,1
0,22.0,Alopecia,16654070,2
1,22.0,Psychological trauma,16654070,6
0,22.0,Alopecia,16654072,2
0,22.0,Breast cancer metastatic,16654219,6
1,22.0,Malignant neoplasm progression,16654219,6
0,22.0,Hypothyroidism,16654277,1
0,22.0,Leukopenia,16654284,2
1,22.0,Troponin increased,16654284,2
2,22.0,Coma,16654284,1
0,22.0,Hyperglycaemia,16654285,2
0,22.0,Breast cancer metastatic,16654299,6
1,22.0,Malignant neoplasm progression,16654299,6
0,22.0,Metastases to bone,16654307,6
1,22.0,Discomfort,16654307,2
2,22.0,Prostatic specific antigen increased,16654307,6
3,22.0,Metastases to bone marrow,16654307,6
0,22.0,Dyspnoea,16654319,5
0,22.0,Ataxia,16654331,6
1,22.0,Encephalitis,16654331,6
0,22.0,Nephritis,16654405,6
0,22.0,Refractory anaemia with an excess of blasts,16654432,3
1,22.0,Myelodysplastic syndrome,16654432,3
0,22.0,Haemoglobin decreased,16654520,2
1,22.0,Bone pain,16654520,3
2,22.0,Madarosis,16654520,2
3,22.0,Dyspnoea,16654520,3
4,22.0,Pulmonary oedema,16654520,3
5,22.0,Memory impairment,16654520,6
6,22.0,Cognitive disorder,16654520,6
7,22.0,Platelet count decreased,16654520,2
8,22.0,White blood cell count decreased,16654520,2
0,22.0,Hospitalisation,16656033,
0,22.0,Pneumonia,16656095,
0,22.0,Disease progression,16656096,
0,22.0,Pain,16656101,
1,22.0,Constipation,16656101,
2,22.0,Stomatitis,16656101,
0,22.0,Decreased appetite,16656863,
1,22.0,Diarrhoea,16656863,
2,22.0,Nausea,16656863,
0,22.0,Nausea,16766875,
1,22.0,Dyspnoea,16766875,
0,22.0,Myalgia,16766892,
1,22.0,Asthenia,16766892,
2,22.0,Fatigue,16766892,
0,22.0,Diarrhoea,16767149,
1,22.0,Dehydration,16767149,
0,22.0,Alopecia,16767163,
1,22.0,Somnolence,16767163,
0,22.0,Musculoskeletal pain,16767223,
1,22.0,Arthralgia,16767223,
2,22.0,Pain in extremity,16767223,
0,22.0,Muscular weakness,16767891,
1,22.0,Pruritus,16767891,
0,22.0,Sepsis,16767895,
1,22.0,Dehydration,16767895,
0,22.0,Rash,16767910,
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,16768207,
0,22.0,Alopecia,16768209,
0,22.0,Insomnia,16768216,
1,22.0,Nausea,16768216,
2,22.0,Fatigue,16768216,
3,22.0,Peripheral swelling,16768216,
0,22.0,Diarrhoea,16768312,
0,22.0,Diarrhoea,16768606,
1,22.0,Disease progression,16768606,
0,22.0,Nausea,16768672,
1,22.0,Vomiting,16768672,
2,22.0,Diarrhoea,16768672,
0,22.0,Death,16770868,
0,22.0,Abdominal pain upper,16771855,
1,22.0,Nausea,16771855,
2,22.0,Diarrhoea,16771855,
0,22.0,Dizziness,16771952,
0,22.0,Neutropenia,16771983,
0,22.0,Stomatitis,16772588,
1,22.0,Constipation,16772588,
0,22.0,Drug ineffective,16772905,
0,22.0,Colitis,16774885,
0,22.0,Feeling abnormal,16775337,
1,22.0,Therapy cessation,16775337,
0,22.0,Toxicity to various agents,16775767,
0,22.0,Swelling face,16776027,
1,22.0,Rash,16776027,
2,22.0,Pruritus,16776027,
3,22.0,Asthenia,16776027,
0,22.0,Therapy change,16776068,
1,22.0,Diarrhoea,16776068,
0,22.0,Neuropathy peripheral,16776087,
1,22.0,Hypoaesthesia oral,16776087,
2,22.0,Dysphagia,16776087,
3,22.0,Paraesthesia oral,16776087,
0,22.0,Bone pain,16776148,
1,22.0,Myalgia,16776148,
0,22.0,Diarrhoea,16776342,
0,22.0,Diarrhoea,16776587,
1,22.0,Dehydration,16776587,
0,22.0,Condition aggravated,16779716,
1,22.0,Cataract,16779716,
2,22.0,Visual impairment,16779716,
0,22.0,Abdominal pain,16780054,
1,22.0,Hypersomnia,16780054,
2,22.0,Dizziness postural,16780054,
3,22.0,Dyspnoea exertional,16780054,
4,22.0,Disorganised speech,16780054,
5,22.0,Neuropathy peripheral,16780054,
6,22.0,Skin exfoliation,16780054,
7,22.0,Stomatitis,16780054,
8,22.0,Balance disorder,16780054,
9,22.0,Bone pain,16780054,
10,22.0,Constipation,16780054,
11,22.0,Fatigue,16780054,
12,22.0,Asthenia,16780054,
13,22.0,Diarrhoea,16780054,
0,22.0,Blister,16780384,
0,22.0,Diarrhoea,16780526,
1,22.0,Therapy cessation,16780526,
2,22.0,Dyspnoea,16780526,
3,22.0,Dehydration,16780526,
0,22.0,Disease progression,16781832,
0,22.0,Oral pain,16782277,
0,22.0,Fatigue,16784457,
1,22.0,Pancytopenia,16784457,
2,22.0,Dizziness,16784457,
3,22.0,Toxicity to various agents,16784457,
4,22.0,Presyncope,16784457,
5,22.0,Acute kidney injury,16784457,
6,22.0,Deafness,16784457,
7,22.0,Failure to thrive,16784457,
8,22.0,Balance disorder,16784457,
9,22.0,Physical deconditioning,16784457,
10,22.0,Tinnitus,16784457,
0,22.0,Blood pressure increased,16784464,
0,22.0,Chemotherapy,16784548,
0,22.0,Death,16784882,
0,22.0,Arthralgia,16784886,
1,22.0,Hypoaesthesia,16784886,
2,22.0,Product dose omission,16784886,
0,22.0,Disease progression,16785370,
1,22.0,Therapy cessation,16785370,
0,22.0,Paraesthesia,16785618,
1,22.0,Skin discolouration,16785618,
0,22.0,Product dose omission,16785651,
1,22.0,Infection,16785651,
0,22.0,Off label use,16785664,
0,22.0,Diarrhoea,16786123,
0,22.0,Disease progression,16786155,
0,22.0,Musculoskeletal pain,16786217,
0,22.0,Urticaria,16786616,
0,22.0,Haemoglobin decreased,16786674,
1,22.0,Fatigue,16786674,
0,22.0,Hot flush,16786902,
0,22.0,Off label use,16786903,
0,22.0,Oral pain,16787666,
1,22.0,Therapy cessation,16787666,
0,22.0,Hyperaesthesia teeth,16789797,
1,22.0,Tendon pain,16789797,
0,22.0,Nausea,16789896,
1,22.0,Feeling abnormal,16789896,
0,22.0,Headache,16789906,
1,22.0,Chills,16789906,
2,22.0,Nausea,16789906,
3,22.0,Pyrexia,16789906,
4,22.0,Vomiting,16789906,
5,22.0,Neutropenia,16789906,
6,22.0,Influenza,16789906,
0,22.0,Disease progression,16790095,
0,22.0,Therapy cessation,16790240,
1,22.0,Disease progression,16790240,
0,22.0,Disease progression,16790318,
0,22.0,Cardiac operation,16790332,
0,22.0,Off label use,16790461,
0,22.0,Insomnia,16790479,
0,22.0,Amnesia,16790582,
1,22.0,Myalgia,16790582,
0,22.0,Hospitalisation,16791810,
1,22.0,Therapy cessation,16791810,
0,22.0,Febrile neutropenia,16794093,
0,22.0,Stomatitis,16794900,
0,22.0,Hepatic enzyme increased,16796926,
0,22.0,Drug level abnormal,16798499,
1,22.0,Wrong schedule,16798499,
0,22.0,Death,16798514,
0,22.0,Pneumonitis,16798643,
1,22.0,Sepsis,16798643,
2,22.0,Computerised tomogram abnormal,16798643,
3,22.0,Cough,16798643,
4,22.0,Chest X-ray abnormal,16798643,
0,22.0,Colonoscopy,16798955,
0,22.0,Product dose omission,16798959,
1,22.0,Hot flush,16798959,
0,22.0,Hospitalisation,16799019,
0,22.0,Therapy cessation,16799135,
1,22.0,Mastectomy,16799135,
0,22.0,White blood cell count decreased,16799201,
0,22.0,Spinal fracture,16799406,
1,22.0,Fall,16799406,
2,22.0,Head injury,16799406,
0,22.0,Death,16799632,
0,22.0,Nausea,16800318,
0,22.0,Diarrhoea,16800358,
0,22.0,Death,16800529,
0,22.0,Urinary tract infection,16800536,
0,22.0,Drug ineffective,16800641,
0,22.0,Rash pruritic,16800814,
0,22.0,Abdominal pain,16803289,
0,22.0,Vision blurred,16804048,
1,22.0,Alopecia,16804048,
2,22.0,Visual impairment,16804048,
0,22.0,Hypoaesthesia,16804762,
1,22.0,Constipation,16804762,
2,22.0,Fatigue,16804762,
3,22.0,Paraesthesia,16804762,
0,22.0,Drug ineffective,16804847,
0,22.0,Injection site swelling,16804905,
0,22.0,Stomatitis,16805073,
1,22.0,Rash,16805073,
0,22.0,Hair growth rate abnormal,16805523,
0,22.0,Death,16805527,
0,22.0,Neck pain,16806174,
0,22.0,Off label use,16806216,
0,22.0,Erythema,16806772,
1,22.0,Swelling face,16806772,
2,22.0,Skin disorder,16806772,
3,22.0,Skin warm,16806772,
0,22.0,Muscle fatigue,16808713,
1,22.0,Fatigue,16808713,
0,22.0,Gastrointestinal haemorrhage,16809605,
0,22.0,Pneumonia,16809846,
0,22.0,Disease complication,16809867,
0,22.0,Off label use,16809956,
0,22.0,Drug ineffective,16813930,
0,22.0,Fatigue,16814398,
1,22.0,Eye haemorrhage,16814398,
2,22.0,Asthenia,16814398,
0,22.0,Hot flush,16815757,
0,22.0,Fatigue,16816728,
1,22.0,Vision blurred,16816728,
2,22.0,Myopia,16816728,
3,22.0,Oedema peripheral,16816728,
0,22.0,Neuropathy peripheral,16816876,
1,22.0,Weight decreased,16816876,
0,22.0,Haemorrhage,16816922,
1,22.0,Skin exfoliation,16816922,
0,22.0,Dehydration,16816934,
1,22.0,Diarrhoea,16816934,
0,22.0,Paraesthesia,16820106,
1,22.0,Pain in extremity,16820106,
2,22.0,Musculoskeletal stiffness,16820106,
0,22.0,Nausea,16820695,
0,22.0,Contusion,16820701,
1,22.0,Thrombocytopenia,16820701,
0,22.0,Thrombosis,16820761,
1,22.0,Hypoaesthesia,16820761,
2,22.0,Fatigue,16820761,
0,22.0,Chills,16820783,
1,22.0,Oedema,16820783,
2,22.0,Neutropenia,16820783,
3,22.0,Paronychia,16820783,
0,22.0,Disease progression,16820816,
0,22.0,Thrombosis,16820895,
1,22.0,Hypoaesthesia,16820895,
0,22.0,Pain in extremity,16821205,
0,22.0,Mental status changes,16821863,
1,22.0,Asthenia,16821863,
0,22.0,Asthenia,16822011,
1,22.0,Mental status changes,16822011,
0,22.0,Taste disorder,16822191,
0,22.0,Eye disorder,16822259,
1,22.0,Eye discharge,16822259,
0,22.0,Skin discolouration,16822265,
1,22.0,Erythema,16822265,
0,22.0,Dyspnoea,16822368,
1,22.0,Chest pain,16822368,
2,22.0,Arteriosclerosis coronary artery,16822368,
0,22.0,Abdominal pain upper,16822383,
0,22.0,Dyspnoea,16822815,
1,22.0,Chest pain,16822815,
2,22.0,Atrioventricular block complete,16822815,
0,22.0,Gastrointestinal haemorrhage,16825773,
1,22.0,Gastric haemorrhage,16825773,
2,22.0,Haemoglobin decreased,16825773,
0,22.0,Melaena,16825876,
1,22.0,Gastrointestinal haemorrhage,16825876,
2,22.0,Haemoglobin decreased,16825876,
0,22.0,Death,16826703,
0,22.0,Disease progression,16826765,
0,22.0,Diarrhoea,16826898,
0,22.0,Product dispensing error,16827040,
0,22.0,Tumour marker increased,16827074,
1,22.0,Insurance issue,16827074,
2,22.0,Therapy cessation,16827074,
0,22.0,Alopecia,16827136,
1,22.0,Fatigue,16827136,
2,22.0,Full blood count decreased,16827136,
0,22.0,Hot flush,16827700,
1,22.0,Blood testosterone decreased,16827700,
0,22.0,Pyrexia,16827722,
1,22.0,Stomatitis,16827722,
2,22.0,Oedema peripheral,16827722,
0,22.0,Arthralgia,16827876,
0,22.0,Hospitalisation,16827899,
0,22.0,Chapped lips,16827940,
1,22.0,Headache,16827940,
2,22.0,Urinary tract infection,16827940,
0,22.0,Wrong technique in product usage process,16827977,
0,22.0,Nausea,16828014,
1,22.0,Pyrexia,16828014,
2,22.0,Stomatitis,16828014,
3,22.0,Oedema peripheral,16828014,
0,22.0,Rash,16828591,
0,22.0,White blood cell count decreased,16829355,
1,22.0,Infection,16829355,
2,22.0,Therapy cessation,16829355,
0,22.0,Prostatic specific antigen increased,16830704,
1,22.0,Decreased appetite,16830704,
2,22.0,Ageusia,16830704,
0,22.0,Rash,16831408,
0,22.0,Choking,16831774,
0,22.0,Disease progression,16832211,
0,22.0,Death,16832307,
0,22.0,Oral mucosal blistering,16832865,
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16832865,
0,22.0,Diarrhoea,16833014,
1,22.0,Sepsis,16833014,
0,22.0,Abdominal discomfort,16833608,
1,22.0,Diarrhoea,16833608,
0,22.0,Adverse reaction,16837685,
0,22.0,Weight increased,16838022,
1,22.0,Poor quality sleep,16838022,
0,22.0,Renal impairment,16838622,
1,22.0,Therapy cessation,16838622,
0,22.0,Decreased appetite,16839355,
1,22.0,Fatigue,16839355,
2,22.0,Diarrhoea,16839355,
3,22.0,Confusional state,16839355,
0,22.0,Fatigue,16839615,
1,22.0,Nausea,16839615,
2,22.0,Ageusia,16839615,
3,22.0,Decreased appetite,16839615,
4,22.0,Dry skin,16839615,
5,22.0,Dizziness,16839615,
6,22.0,Weight decreased,16839615,
7,22.0,Dry mouth,16839615,
8,22.0,Diarrhoea,16839615,
0,22.0,Coma,16654582,1
1,22.0,Leukopenia,16654582,2
2,22.0,Troponin increased,16654582,2
0,22.1,Hepatocellular injury,16654702,2
1,22.1,Cholestasis,16654702,2
0,22.0,Depressed level of consciousness,16654799,6
1,22.0,Death,16654799,5
2,22.0,Memory impairment,16654799,1
0,22.0,Renal disorder,16654801,6
1,22.0,Anaemia,16654801,6
0,22.0,Rash,16654802,1
1,22.0,Tachycardia,16654802,1
2,22.0,Dyspnoea,16654802,1
0,22.0,Disseminated intravascular coagulation,16654814,1
1,22.0,Febrile neutropenia,16654814,3
0,22.0,Asthma,16654862,6
1,22.0,Overdose,16654862,6
0,22.0,Paraparesis,16654883,6
0,22.0,Urinary tract infection,16654918,1
0,22.0,Rash,16654919,1
0,22.0,Small intestinal obstruction,16654929,6
1,22.0,Pneumonia,16654929,6
2,22.0,Ileus,16654929,2
0,22.0,Dental cleaning,16654943,6
1,22.0,Off label use,16654943,6
2,22.0,Tooth repair,16654943,6
0,22.0,Dyshidrotic eczema,16654945,1
1,22.0,Urinary tract infection,16654945,1
2,22.0,Erysipelas,16654945,1
3,22.0,Sinus tachycardia,16654945,1
4,22.0,Pulmonary embolism,16654945,1
5,22.0,Dyspnoea,16654945,6
6,22.0,Peripheral sensory neuropathy,16654945,3
7,22.0,Off label use,16654945,6
8,22.0,Cystitis noninfective,16654945,1
9,22.0,Tachycardia,16654945,6
10,22.0,Depression,16654945,1
11,22.0,Dysphagia,16654945,3
12,22.0,Influenza like illness,16654945,1
13,22.0,Borrelia infection,16654945,1
0,22.0,Dizziness,16654951,6
1,22.0,Nausea,16654951,6
2,22.0,Therapeutic product effect incomplete,16654951,6
3,22.0,Therapeutic response unexpected,16654951,6
4,22.0,Vomiting,16654951,6
0,22.0,Eosinophilic pneumonia,16654955,6
1,22.0,Off label use,16654955,6
0,22.0,Cholangitis sclerosing,16654977,3
0,22.0,Lung disorder,16655032,1
0,22.0,No adverse event,16655084,6
1,22.0,Off label use,16655084,6
2,22.0,Intentional product use issue,16655084,6
0,22.0,Dehydration,16655147,1
1,22.0,Drug intolerance,16655147,6
2,22.0,Diarrhoea,16655147,1
3,22.0,Blood creatinine increased,16655147,3
0,22.0,Abdominal pain,16655148,6
1,22.0,Flatulence,16655148,6
2,22.0,Abdominal distension,16655148,6
0,22.0,Myocardial infarction,16655199,1
1,22.0,Diabetes mellitus,16655199,3
2,22.0,Hypertriglyceridaemia,16655199,3
0,22.0,Myalgia,16655223,3
1,22.0,Bone pain,16655223,6
2,22.0,Decreased appetite,16655223,3
3,22.0,Blood pressure increased,16655223,6
4,22.0,Epistaxis,16655223,3
0,22.0,Influenza like illness,16655258,6
1,22.0,Febrile neutropenia,16655258,6
2,22.0,Off label use,16655258,6
0,22.0,Hyperbilirubinaemia,16655288,2
0,22.0,Paraesthesia,16655341,6
1,22.0,Treatment noncompliance,16655341,6
2,22.0,Hepatotoxicity,16655341,6
3,22.0,Hypoaesthesia,16655341,6
4,22.0,Neuropathy peripheral,16655341,6
5,22.0,Off label use,16655341,6
0,22.0,Decreased appetite,16655348,1
1,22.0,Malaise,16655348,1
2,22.0,Diarrhoea,16655348,1
0,22.0,Drug interaction,16655450,3
1,22.0,Prostatic specific antigen increased,16655450,3
2,22.0,Hypoaesthesia,16655450,3
3,22.0,Nausea,16655450,3
4,22.0,Pain,16655450,3
0,22.0,Prescribed underdose,16655454,6
1,22.0,Death,16655454,5
0,22.0,Wrong technique in product usage process,16655463,6
1,22.0,Weight bearing difficulty,16655463,6
2,22.0,Joint swelling,16655463,6
0,22.0,Drug ineffective,16655530,6
1,22.0,Pituitary tumour benign,16655530,6
2,22.0,Blood testosterone increased,16655530,6
0,22.0,Thrombocytopenia,16655536,6
0,22.0,Hot flush,16655540,6
0,22.0,Pneumonia,16655581,2
0,22.0,Hypertension,16655585,1
1,22.0,Purpura,16655585,1
0,22.0,Sepsis,16655590,5
1,22.0,Diarrhoea,16655590,5
2,22.0,Febrile neutropenia,16655590,5
3,22.0,Renal failure,16655590,5
4,22.0,Stomatitis,16655590,5
0,22.1,Altered state of consciousness,16655592,1
1,22.1,Lung disorder,16655592,2
2,22.1,Visual acuity reduced,16655592,1
3,22.1,Posterior reversible encephalopathy syndrome,16655592,1
0,22.1,Urticaria,16655601,1
0,22.0,Rash generalised,16655605,1
0,22.1,Pyrexia,16655721,6
1,22.1,Influenza like illness,16655721,6
2,22.1,Insomnia,16655721,6
3,22.1,Neuropathy peripheral,16655721,3
4,22.1,Nausea,16655721,6
0,22.0,Off label use,16655724,6
1,22.0,Hypoacusis,16655724,2
2,22.0,Febrile bone marrow aplasia,16655724,1
0,22.0,Intentional product use issue,16655782,6
1,22.0,Death,16655782,5
2,22.0,Off label use,16655782,6
0,22.0,Bone marrow failure,16655787,2
0,22.0,Product use complaint,16655877,3
1,22.0,Oesophageal carcinoma,16655877,3
2,22.0,Dysphagia,16655877,3
3,22.0,Product size issue,16655877,6
0,22.0,Malignant neoplasm progression,16655945,5
0,22.1,Myocarditis,16655960,2
1,22.1,Atrial fibrillation,16655960,2
2,22.1,Cardiac failure,16655960,6
0,22.0,Neutrophil count decreased,16655971,6
1,22.0,Proteinuria,16655971,6
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16655971,6
3,22.0,Anaemia,16655971,6
4,22.0,Hypertension,16655971,6
0,22.0,Brain neoplasm,16655978,6
0,22.0,Cardiomyopathy,16655997,2
1,22.0,Drug ineffective,16655997,6
2,22.0,Cardiac failure congestive,16655997,6
3,22.0,Hypovolaemia,16655997,6
4,22.0,Hypotension,16655997,6
0,22.0,Drug interaction,16656012,6
1,22.0,Oesophagitis,16656012,6
2,22.0,Gastritis erosive,16656012,6
0,22.0,Skin infection,16656017,2
1,22.0,Limb discomfort,16656017,2
2,22.0,Clostridium difficile infection,16656017,2
0,22.0,Neuropathy peripheral,16656028,3
1,22.0,Blister,16656028,
2,22.0,Gait inability,16656028,
3,22.0,Diarrhoea,16656028,6
4,22.0,Blood potassium decreased,16656028,6
5,22.0,Adverse event,16656028,6
6,22.0,Adverse drug reaction,16656028,
7,22.0,Gait disturbance,16656028,6
8,22.0,Pain in extremity,16656028,
0,22.1,Terminal state,16656057,6
1,22.1,Death,16656057,5
2,22.1,Abdominal pain,16656057,6
0,22.0,Pulmonary toxicity,16656087,6
0,22.0,Pulmonary toxicity,16656088,6
0,22.0,Appendicitis,16656115,1
0,22.0,Oedema peripheral,16656172,1
1,22.0,Enterovesical fistula,16656172,1
0,22.0,Tinnitus,16656175,3
0,22.0,Neoplasm progression,16656177,3
1,22.0,Bronchiectasis,16656177,3
2,22.0,Fatigue,16656177,3
3,22.0,Pain,16656177,3
4,22.0,Pleural effusion,16656177,3
0,22.0,Acute myeloid leukaemia,16656182,3
1,22.0,Second primary malignancy,16656182,3
0,22.0,Blood count abnormal,16656183,6
0,22.0,Death,16656184,5
0,22.0,Diarrhoea,16656189,6
1,22.0,Cough,16656189,6
2,22.0,Weight decreased,16656189,6
3,22.0,Lymphadenopathy mediastinal,16656189,6
4,22.0,Neoplasm progression,16656189,6
0,22.0,Colorectal cancer,16656240,
1,22.0,Rash,16656240,2
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16656240,2
0,22.0,Atrioventricular block first degree,16656366,1
1,22.0,Defect conduction intraventricular,16656366,1
0,22.0,Diarrhoea,16656368,2
1,22.0,Decreased appetite,16656368,6
0,22.0,Off label use,16656391,6
0,22.0,Off label use,16656404,
0,22.0,Death,16656408,5
1,22.0,Intentional product use issue,16656408,6
0,22.0,Ejection fraction decreased,16656468,6
1,22.0,Electrocardiogram abnormal,16656468,6
2,22.0,Angina pectoris,16656468,6
0,22.0,Dry mouth,16656469,1
1,22.0,Neutropenia,16656469,1
0,22.0,Rhinorrhoea,16656470,1
1,22.0,Neutropenia,16656470,1
2,22.0,Diarrhoea,16656470,3
3,22.0,Cough,16656470,1
4,22.0,Asthenia,16656470,1
5,22.0,Headache,16656470,1
6,22.0,Polyneuropathy,16656470,1
7,22.0,Dry skin,16656470,3
8,22.0,Dysuria,16656470,1
0,22.0,Fatigue,16656501,3
1,22.0,Hot flush,16656501,3
2,22.0,Muscle swelling,16656501,3
3,22.0,Nausea,16656501,3
4,22.0,Rash,16656501,3
5,22.0,Hypertension,16656501,3
6,22.0,Neutropenia,16656501,3
7,22.0,Pain,16656501,3
8,22.0,Constipation,16656501,3
9,22.0,Headache,16656501,3
0,22.0,Pneumothorax,16656512,1
0,22.0,Subacute cutaneous lupus erythematosus,16656515,6
0,22.1,Intra-abdominal fluid collection,16656518,1
1,22.1,Pulmonary embolism,16656518,2
2,22.1,Post procedural fever,16656518,1
0,22.0,Intestinal perforation,16656528,6
1,22.0,Cardiac failure,16656528,6
2,22.0,Cardiac arrest,16656528,6
3,22.0,Abdominal pain,16656528,6
4,22.0,Colitis,16656528,6
5,22.0,Intestinal ischaemia,16656528,6
6,22.0,Diarrhoea,16656528,6
0,22.0,Fatigue,16656583,6
1,22.0,Haemoglobin decreased,16656583,6
2,22.0,Neutrophil count decreased,16656583,6
3,22.0,Neoplasm progression,16656583,6
0,22.1,Hypertension,16656591,6
1,22.1,Condition aggravated,16656591,2
2,22.1,Head injury,16656591,6
3,22.1,Product prescribing error,16656591,6
4,22.1,Trigeminal neuralgia,16656591,2
5,22.1,Weight decreased,16656591,6
6,22.1,Feeding disorder,16656591,6
7,22.1,Therapeutic product effect incomplete,16656591,6
8,22.1,Fall,16656591,6
9,22.1,Sleep disorder,16656591,6
0,22.1,Neoplasm progression,16656649,6
0,22.0,Diarrhoea,16656686,1
1,22.0,Malaise,16656686,1
2,22.0,Decreased appetite,16656686,1
0,22.0,Asthenia,16656725,1
1,22.0,Physical deconditioning,16656725,1
0,22.1,Toothache,16656749,3
1,22.1,Somnolence,16656749,6
2,22.1,Asthenia,16656749,2
3,22.1,Malaise,16656749,6
4,22.1,Abdominal pain,16656749,3
5,22.1,Fatigue,16656749,3
6,22.1,Mobility decreased,16656749,6
0,22.0,Product use in unapproved indication,16656809,6
1,22.0,Death,16656809,5
0,22.0,Dyspnoea,16656849,6
1,22.0,Myocardial infarction,16656849,2
0,22.0,Gait inability,16656890,3
1,22.0,Aggression,16656890,6
2,22.0,Malaise,16656890,3
3,22.0,Injection site reaction,16656890,6
4,22.0,Tachycardia,16656890,3
5,22.0,Memory impairment,16656890,3
6,22.0,Yellow skin,16656890,3
7,22.0,Feeling hot,16656890,3
8,22.0,Muscular weakness,16656890,3
9,22.0,Blood pressure decreased,16656890,6
10,22.0,Injection site mass,16656890,3
11,22.0,Hot flush,16656890,3
12,22.0,Arthralgia,16656890,3
13,22.0,Cardiac murmur,16656890,6
14,22.0,Ocular icterus,16656890,3
15,22.0,Suicidal ideation,16656890,6
16,22.0,Injection site pain,16656890,3
17,22.0,Anger,16656890,6
18,22.0,Blood cholesterol increased,16656890,6
19,22.0,Dyspnoea,16656890,3
20,22.0,Pyrexia,16656890,3
21,22.0,Fatigue,16656890,3
22,22.0,Nausea,16656890,3
23,22.0,Dyspnoea,16656890,1
24,22.0,Hypertension,16656890,3
0,22.0,Diarrhoea,16656893,1
1,22.0,Pyrexia,16656893,1
2,22.0,Tumour lysis syndrome,16656893,1
0,22.0,Anaemia macrocytic,16656915,6
0,22.1,Asthenia,16656918,3
1,22.1,Injection site pain,16656918,3
2,22.1,Incontinence,16656918,3
3,22.1,Muscle atrophy,16656918,3
4,22.1,Injection site mass,16656918,3
5,22.1,Hot flush,16656918,3
6,22.1,Pain,16656918,3
0,22.0,Oropharyngeal pain,16656980,2
1,22.0,Musculoskeletal pain,16656980,2
2,22.0,Respiratory arrest,16656980,5
3,22.0,Dysphagia,16656980,2
0,22.0,Colitis,16657003,3
0,22.0,Death,16657008,5
0,22.0,Myocardial infarction,16657009,6
0,22.0,Dysphagia,16657033,6
1,22.0,Muscle spasms,16657033,6
2,22.0,Death,16657033,5
0,22.0,Rash,16657072,6
0,22.0,Death,16657082,5
1,22.0,Fall,16657082,5
2,22.0,Malaise,16657082,5
0,22.0,Death,16657116,5
0,22.1,Death,16657164,5
1,22.1,Diarrhoea,16657164,1
2,22.1,Hypoacusis,16657164,6
3,22.1,Decreased appetite,16657164,6
4,22.1,Anxiety,16657164,6
5,22.1,Rash,16657164,6
0,22.0,Lymphoedema,16657255,2
0,22.0,Decubitus ulcer,16657263,1
0,22.0,Emotional distress,16657332,6
1,22.0,Impaired quality of life,16657332,6
2,22.0,Psychological trauma,16657332,6
3,22.0,Alopecia,16657332,2
4,22.0,Pain,16657332,6
5,22.0,Anxiety,16657332,6
0,22.1,Tic,16657334,6
0,22.1,Alopecia,16657387,3
1,22.1,Psychological trauma,16657387,6
0,22.1,Pyelonephritis,16657397,2
1,22.1,Cystitis,16657397,6
0,22.1,Alopecia,16657461,3
1,22.1,Emotional distress,16657461,6
2,22.1,Psychological trauma,16657461,6
3,22.1,Impaired quality of life,16657461,6
4,22.1,Pain,16657461,6
5,22.1,Anxiety,16657461,6
0,22.0,Alopecia,16657528,2
0,22.0,Flushing,16657538,1
1,22.0,Drug hypersensitivity,16657538,2
2,22.0,Hypertension,16657538,1
3,22.0,Dyspnoea,16657538,1
4,22.0,Throat tightness,16657538,1
0,22.1,Nausea,16657652,1
1,22.1,Weight decreased,16657652,6
2,22.1,Diarrhoea,16657652,1
3,22.1,White blood cell count decreased,16657652,2
4,22.1,Ocular discomfort,16657652,6
5,22.1,Eye infection,16657652,6
6,22.1,Decreased appetite,16657652,2
7,22.1,Infected bite,16657652,6
8,22.1,Appetite disorder,16657652,6
9,22.1,Gastroenteritis viral,16657652,6
10,22.1,Hot flush,16657652,1
11,22.1,Hepatic steatosis,16657652,6
12,22.1,Dry mouth,16657652,6
13,22.1,Intentional product misuse,16657652,6
14,22.1,Fatigue,16657652,2
15,22.1,Headache,16657652,1
16,22.1,Stomatitis,16657652,1
0,22.1,Hepatitis,16657669,1
0,22.0,Dizziness,16657682,6
1,22.0,Sepsis,16657682,2
2,22.0,Pancytopenia,16657682,6
3,22.0,Discomfort,16657682,6
0,22.0,Disseminated intravascular coagulation,16657729,5
1,22.0,Endocarditis,16657729,5
2,22.0,Sepsis,16657729,5
3,22.0,Platelet count decreased,16657729,3
4,22.0,Rash,16657729,1
0,22.0,Non-small cell lung cancer recurrent,16657738,6
0,22.0,Metabolic acidosis,16657740,1
1,22.0,Hyperkalaemia,16657740,1
2,22.0,Acute kidney injury,16657740,1
3,22.0,Cardio-respiratory arrest,16657740,1
0,22.0,Hypotension,16657775,3
1,22.0,Asthma,16657775,1
2,22.0,Urinary tract infection,16657775,6
3,22.0,Mean cell volume abnormal,16657775,6
4,22.0,Weight decreased,16657775,2
5,22.0,Red cell distribution width increased,16657775,6
6,22.0,Mean cell haemoglobin decreased,16657775,6
7,22.0,Platelet count decreased,16657775,6
8,22.0,Fatigue,16657775,6
9,22.0,Underdose,16657775,6
10,22.0,Pneumonia,16657775,1
11,22.0,Nausea,16657775,6
0,22.1,Myasthenia gravis,16657778,5
0,22.0,Bone marrow failure,16657784,2
0,22.1,Neoplasm progression,16657786,5
0,22.0,Neoplasm progression,16657789,3
1,22.0,Drug intolerance,16657789,6
0,22.1,Urticaria,16657801,1
0,22.0,Radiation necrosis,16657806,2
1,22.0,Pharyngeal fistula,16657806,2
0,22.0,Vomiting,16657821,6
0,22.0,Product use in unapproved indication,16657822,6
1,22.0,Bladder pain,16657822,3
0,22.0,Mucosal inflammation,16657829,6
0,22.0,Nephritis,16657859,2
0,22.0,Fall,16657897,1
1,22.0,Hypotension,16657897,1
0,22.1,Malignant neoplasm progression,16657903,6
1,22.1,Radiation pneumonitis,16657903,2
0,22.0,Troponin increased,16657948,2
1,22.0,Leukopenia,16657948,2
2,22.0,Disturbance in attention,16657948,1
0,22.0,Acute hepatic failure,16658094,6
1,22.0,Hepatitis B reactivation,16658094,6
0,22.0,Dysphagia,16658136,6
1,22.0,Cerebral infarction,16658136,6
0,22.1,Platelet count decreased,16658204,1
1,22.1,Metastases to bone,16658204,6
2,22.1,Anaemia,16658204,3
3,22.1,Jaundice,16658204,3
4,22.1,Metastases to liver,16658204,6
5,22.1,Nail disorder,16658204,3
6,22.1,Metastases to central nervous system,16658204,6
0,22.0,Therapy cessation,16658262,
1,22.0,Disease progression,16658262,
0,22.0,Disease progression,16658268,
0,22.0,Brain neoplasm,16658271,
0,22.0,Death,16658276,
0,22.0,Disease progression,16658285,
0,22.0,Platelet count decreased,16658317,6
1,22.0,Haemoglobin decreased,16658317,6
2,22.0,Neoplasm malignant,16658317,6
3,22.0,Malaise,16658317,6
0,22.0,Anaemia,16658325,3
1,22.0,Neutrophil count decreased,16658325,3
2,22.0,Dehydration,16658325,1
3,22.0,White blood cell count decreased,16658325,3
4,22.0,Hyperkalaemia,16658325,1
5,22.0,Platelet count decreased,16658325,3
6,22.0,Subileus,16658325,1
7,22.0,Stomatitis,16658325,1
8,22.0,Blood creatinine increased,16658325,3
0,22.0,Pneumonia aspiration,16658369,6
0,22.1,Ascites,16658370,1
1,22.1,Lymphatic duct injury,16658370,1
0,22.0,Blood creatine increased,16658372,1
1,22.0,Off label use,16658372,6
0,22.0,Chest pain,16658392,1
1,22.0,Chills,16658392,1
0,22.0,Cystitis,16658405,
0,22.0,Neuropathy peripheral,16658406,6
1,22.0,Product use in unapproved indication,16658406,6
2,22.0,Altered visual depth perception,16658406,6
0,22.0,Blood pressure increased,16658409,1
1,22.0,Erythema,16658409,1
2,22.0,Choking sensation,16658409,1
3,22.0,Burning sensation,16658409,1
0,22.0,White blood cell count decreased,16658420,1
1,22.0,Nausea,16658420,1
2,22.0,Malignant neoplasm progression,16658420,6
3,22.0,Anaemia,16658420,1
0,22.0,Haemophagocytic lymphohistiocytosis,16658494,1
0,22.0,Lung disorder,16658500,1
1,22.0,Pyrexia,16658500,1
0,22.0,Hair growth rate abnormal,16658523,6
1,22.0,Alopecia,16658523,1
0,22.1,Feeling abnormal,16658539,6
1,22.1,Muscle spasms,16658539,1
2,22.1,Decreased appetite,16658539,6
3,22.1,Feeling hot,16658539,6
4,22.1,Gastrointestinal pain,16658539,6
5,22.1,Vomiting,16658539,3
6,22.1,Dysphagia,16658539,6
7,22.1,Nausea,16658539,3
0,22.0,Deafness,16658561,3
0,22.1,Weight decreased,16658576,6
1,22.1,Rash,16658576,1
2,22.1,Diarrhoea,16658576,3
3,22.1,Neutropenia,16658576,1
0,22.1,Product use in unapproved indication,16658581,6
1,22.1,Hypothyroidism,16658581,3
2,22.1,Pleural effusion,16658581,3
0,22.0,Agraphia,16658588,1
0,22.1,Muscular weakness,16658613,1
0,22.0,Metastases to bone,16658676,3
1,22.0,Metastases to lymph nodes,16658676,3
2,22.0,Performance status decreased,16658676,6
3,22.0,Prostatic specific antigen increased,16658676,3
4,22.0,Synovial cyst,16658676,3
5,22.0,Skeletal injury,16658676,3
6,22.0,Asthenia,16658676,6
0,22.0,Colitis ulcerative,16658678,2
1,22.0,Proctitis ulcerative,16658678,2
0,22.0,Weight decreased,16658777,3
1,22.0,Taste disorder,16658777,3
2,22.0,Lymphadenopathy,16658777,3
0,22.0,Drug ineffective,16658818,6
1,22.0,Spinal disorder,16658818,6
0,22.0,Psoriasis,16658820,4
0,22.0,Death,16658821,5
0,22.0,Faecaloma,16658846,6
1,22.0,Vomiting,16658846,6
2,22.0,Diarrhoea,16658846,6
0,22.0,Abdominal pain,16658861,6
1,22.0,Malignant neoplasm progression,16658861,6
2,22.0,Liver function test abnormal,16658861,6
3,22.0,Metastases to bone,16658861,6
4,22.0,Skin lesion,16658861,6
5,22.0,Neuropathy peripheral,16658861,6
6,22.0,Increased liver stiffness,16658861,6
7,22.0,Oestradiol abnormal,16658861,6
8,22.0,Fatigue,16658861,6
9,22.0,Tumour marker increased,16658861,6
10,22.0,PIK3CA-activated mutation,16658861,6
11,22.0,Breast cancer,16658861,6
12,22.0,Colitis,16658861,6
0,22.0,Asthenia,16658899,6
1,22.0,Pyrexia,16658899,6
2,22.0,Constipation,16658899,1
3,22.0,Abdominal pain upper,16658899,6
4,22.0,Concomitant disease aggravated,16658899,6
5,22.0,Fatigue,16658899,3
6,22.0,White blood cell count decreased,16658899,1
0,22.1,Pharyngeal disorder,16658929,6
1,22.1,Hyperthyroidism,16658929,1
2,22.1,Agranulocytosis,16658929,6
0,22.0,Seizure,16658950,3
1,22.0,Product dose omission,16658950,6
0,22.0,Colorectal cancer metastatic,16658961,3
1,22.0,Skin reaction,16658961,3
2,22.0,Drug ineffective,16658961,6
3,22.0,Skin infection,16658961,6
4,22.0,Rash,16658961,6
0,22.0,Anaemia,16658976,6
1,22.0,Myelodysplastic syndrome,16658976,6
0,22.1,Rectal haemorrhage,16658999,3
1,22.1,Hypomagnesaemia,16658999,1
2,22.1,Decreased appetite,16658999,3
3,22.1,Acute kidney injury,16658999,1
4,22.1,Weight decreased,16658999,6
5,22.1,Vomiting,16658999,1
6,22.1,Weight decreased,16658999,3
7,22.1,Diarrhoea,16658999,1
8,22.1,Diarrhoea,16658999,1
9,22.1,Diarrhoea,16658999,1
10,22.1,Back pain,16658999,3
11,22.1,Diarrhoea,16658999,1
12,22.1,Cholelithiasis,16658999,3
13,22.1,Rash pruritic,16658999,1
14,22.1,Disease progression,16658999,5
0,22.0,Pain,16659017,1
1,22.0,Carotid arteriosclerosis,16659017,6
2,22.0,Pain in extremity,16659017,1
3,22.0,Bone marrow failure,16659017,1
4,22.0,Headache,16659017,1
0,22.0,Aspartate aminotransferase increased,16659126,1
1,22.0,Alanine aminotransferase increased,16659126,1
0,22.0,Empyema,16659135,6
1,22.0,Clostridium difficile infection,16659135,3
0,22.0,Carpal tunnel syndrome,16659138,6
0,22.0,Pneumoperitoneum,16659156,1
1,22.0,Intestinal perforation,16659156,1
2,22.0,Pneumatosis intestinalis,16659156,1
0,22.0,Hyperthyroidism,16659218,6
1,22.0,Epistaxis,16659218,6
2,22.0,Anaemia,16659218,6
3,22.0,Atrial flutter,16659218,
0,22.0,Hyperthyroidism,16659222,6
1,22.0,Epistaxis,16659222,6
2,22.0,Anaemia,16659222,6
3,22.0,Atrial flutter,16659222,6
0,22.0,Stevens-Johnson syndrome,16659234,2
0,22.1,Cardiac failure,16659283,4
1,22.1,Atrial fibrillation,16659283,4
0,22.0,Ejection fraction decreased,16659296,6
1,22.0,Electrocardiogram abnormal,16659296,6
2,22.0,Angina pectoris,16659296,6
0,22.0,Ischaemic stroke,16659337,1
0,22.0,Hepatitis,16659360,6
0,22.1,Myocarditis,16659401,5
0,22.0,Blood bilirubin increased,16659419,6
0,22.0,Metastases to bone,16659423,6
1,22.0,Metastases to lung,16659423,6
2,22.0,Malignant neoplasm progression,16659423,6
3,22.0,Breast cancer,16659423,6
0,22.0,Malignant neoplasm progression,16659467,3
0,22.0,Pyrexia,16659471,2
1,22.0,Liver disorder,16659471,2
0,22.0,Granulocyte count decreased,16659473,6
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16659473,6
2,22.0,Haemoglobin decreased,16659473,6
3,22.0,Diarrhoea,16659473,6
4,22.0,Nausea,16659473,6
5,22.0,Liver injury,16659473,6
6,22.0,Phlebitis,16659473,6
7,22.0,Vomiting,16659473,6
0,22.0,Malignant neoplasm progression,16659491,3
0,22.0,Malaise,16659494,1
1,22.0,Dyspnoea,16659494,1
2,22.0,Dyspnoea,16659494,1
3,22.0,Dyspnoea,16659494,4
0,22.0,Peritonitis,16659511,5
1,22.0,Intestinal perforation,16659511,5
2,22.0,Sepsis,16659511,5
0,22.0,Pharyngeal oedema,16659513,2
1,22.0,Dysphonia,16659513,2
2,22.0,Abdominal pain,16659513,2
3,22.0,Dysarthria,16659513,2
0,22.0,Neoplasm progression,16659531,5
0,22.0,Delirium,16659532,1
0,22.0,Cerebral haemorrhage,16659550,5
1,22.0,Cardiac disorder,16659550,3
0,22.0,Loss of control of legs,16659558,6
1,22.0,Dysuria,16659558,6
2,22.0,Fatigue,16659558,6
3,22.0,Drug intolerance,16659558,6
4,22.0,Product dose omission,16659558,6
5,22.0,Constipation,16659558,6
0,22.0,Total bile acids increased,16659566,2
0,22.1,Death,16659572,5
1,22.1,Blood pressure fluctuation,16659572,6
2,22.1,Hypoacusis,16659572,6
3,22.1,Parkinson^s disease,16659572,6
0,22.0,Mental status changes,16659617,1
1,22.0,Encephalitis,16659617,3
2,22.0,Acute kidney injury,16659617,1
0,22.1,Neurological decompensation,16659650,5
1,22.1,General physical health deterioration,16659650,3
2,22.1,Neuropathy peripheral,16659650,6
3,22.1,Metastases to central nervous system,16659650,6
4,22.1,Disease progression,16659650,5
5,22.1,Vomiting,16659650,5
6,22.1,Headache,16659650,5
7,22.1,Breast cancer,16659650,6
8,22.1,Intentional product use issue,16659650,6
9,22.1,Malignant neoplasm progression,16659650,6
10,22.1,Off label use,16659650,6
0,22.0,Colon cancer,16659687,6
1,22.0,Dermatitis acneiform,16659687,1
2,22.0,Disease progression,16659687,6
0,22.0,White blood cell count increased,16659692,3
0,22.0,Pancreatitis,16659717,1
1,22.0,Off label use,16659717,6
0,22.0,Erosive oesophagitis,16659733,6
1,22.0,Gastrointestinal haemorrhage,16659733,6
2,22.0,Drug interaction,16659733,6
3,22.0,International normalised ratio fluctuation,16659733,6
4,22.0,Overdose,16659733,6
5,22.0,Therapeutic product effect decreased,16659733,6
6,22.0,Gastritis erosive,16659733,6
0,22.0,Febrile neutropenia,16659739,5
1,22.0,Abdominal pain,16659739,3
2,22.0,Enterocolitis,16659739,6
3,22.0,Intestinal obstruction,16659739,6
4,22.0,Platelet count decreased,16659739,6
5,22.0,White blood cell count decreased,16659739,5
6,22.0,Loss of consciousness,16659739,6
7,22.0,Asthenia,16659739,5
8,22.0,Neutropenic infection,16659739,5
9,22.0,Shock,16659739,5
10,22.0,Constipation,16659739,3
0,22.0,Bradycardia,16659782,6
0,22.0,Myelodysplastic syndrome,16659829,3
1,22.0,Second primary malignancy,16659829,3
0,22.0,Osteoporosis,16659899,6
0,22.0,Pyrexia,16659924,1
1,22.0,Arthralgia,16659924,1
2,22.0,Liver disorder,16659924,1
0,22.0,Thrombocytopenia,16659942,6
0,22.0,Cardiogenic shock,16659965,2
1,22.0,Stress cardiomyopathy,16659965,2
2,22.0,Orthopnoea,16659965,2
3,22.0,Cardiac failure,16659965,1
4,22.0,Chest pain,16659965,2
5,22.0,Pulmonary oedema,16659965,2
6,22.0,Dyspnoea,16659965,2
7,22.0,Rales,16659965,2
